| Product name: |
Trifexis 1620/27 mg |
| Active substance: |
Milbemycinoximum, Spinosadum |
| Target tribe: |
psi |
| Drug form: |
Žvýkací tableta |
| Registration date: |
19. 9. 2013 |
| Registration number: |
EU/2/13/155 |
| Verdict holder: |
Eli Lilly and Company Ltd., Elanco Animal Health
Priestley Road,
Basingstoke, Hampshire RG24 9NL
Phone: , Fax:
Email: |
| ATC vet. code: |
QP54AB - Milbemycin oxime, combinations |
| Pharmacotherapeutic group: |
Milbemycins |
| Narcotics: |
NO |
| Indication restriction: |
NO |
| Withdrawal period: |
|
| Procedure type: |
Centralised |
Table of active package codes| Package code | Size | Package type | Material | Identification code | EU number | Issue |
|---|
| 9902792 | 1 x 1 tableta | blistr | - | - | - | Na předpis | | 9902793 | 1 x 3 tableta | blistr | - | - | - | Na předpis | | 9902794 | 1 x 6 tableta | blistr | - | - | - | Na předpis |
| Package code | Size | Package type | Material | Identification code | EU number | Issue |
|---|
|
Authorisation & Approval 
